Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich

Michael Pritsch, Katja Radon, Abhishek Bakuli, Ronan Le Gleut, Laura Olbrich, Jessica Guggenbüehl Noller, Elmar Saathoff, Noemi Castelletti, Mercè Garí, Peter Pütz, Yannik Schälte, Turid Frahnow, Roman Wölfel, Camilla Rothe, Michel Pletschette, Dafni Metaxa, Felix Forster, Verena Thiel, F. Rieß, Maximilian N. Diefenbach, Günter Fröschl, Jan Bruger, Simon Winter, Jonathan Frese, Kerstin Puchinger, Isabel Brand, Inge Kroidl, Jan Hasenauer, Christiane Fuchs, Andreas Wieser, Michael Höelscher, on behalf of the KoCo19 study groupInternational Journal of Environmental Research and Public Health 2021 · DOI

TL;DR

This study provides a crucial population-based estimate of SARS-CoV-2 seroprevalence in Munich after the first wave, revealing a significantly higher infection rate than officially reported PCR cases. It highlights that only a fraction of infections were detected by the healthcare system, underscoring the challenge of accurately tracking pandemics and informing public health strategies.

What Problem Does This Paper Address?

The COVID-19 pandemic's true scale is difficult to ascertain solely from official case counts, as many infections are mild or asymptomatic and go unreported. This lack of comprehensive data hinders accurate estimations of disease burden, true reproduction numbers, and attack rates, making evidence-based public health decision-making challenging. This paper addresses this by conducting a population-based serosurvey in Munich to estimate the seroprevalence of SARS-CoV-2 antibodies after the first wave, aiming to provide a more complete picture of the pandemic's impact.

Methods

The researchers employed a population-based cohort study design, sampling 2994 private households in Munich. Participants aged 14 and older provided blood samples for antibody testing using the Roche N pan-Ig assay, with an optimized cutoff of 0.4218 for seropositivity. To account for potential biases, prevalence estimates were adjusted for the sampling design, as well as the sensitivity and specificity of the testing assay. Risk factor analyses were conducted using logistic regression (GLM) and generalized linear mixed models (GLMM) to account for household clustering. Geospatial transmission patterns were investigated using permutation tests.

Datasets

The study utilized data from 2994 private households in Munich, comprising 5313 individuals aged 14 and older who provided blood samples. This dataset was compared against official Munich population data for demographic characteristics. The study also referenced official COVID-19 case and mortality data from the Statistical Office of the City of Munich and the Robert Koch Institute (RKI) for Germany.

Key Insights and Ideas

  • Underestimation of Pandemic Scale: The most striking insight is the significant underestimation of SARS-CoV-2 infections by official PCR case reporting. The seroprevalence was substantially higher, indicating that the true burden of disease was much greater than initially apparent.
  • Importance of Population-Based Studies: This research underscores the critical role of population-based serosurveys in providing a more accurate picture of pandemic spread, especially when mild or asymptomatic cases are prevalent.
  • Household Clustering: The study confirmed that SARS-CoV-2 infections tend to cluster within households, highlighting the importance of household-level interventions and understanding transmission dynamics within families.
  • Symptom Association: Loss of smell or taste was strongly associated with seropositivity, reinforcing its utility as a key indicator of past infection, even when reported weeks after the event.

Key Results

  • The adjusted seroprevalence of SARS-CoV-2 antibodies in the Munich general population (aged 14+) after the first wave was 1.82% (95% CI 1.28–2.37%).
  • This seroprevalence was approximately four times higher than the officially registered PCR-positive cases (0.46%).
  • The study estimated that about one in four SARS-CoV-2 infections in private households were reported to health authorities.
  • Loss of the sense of smell or taste was a significant risk factor for seropositivity, with an odds ratio (OR) of 47.4 (95% CI 7.2–307.0).
  • Infections showed a statistically significant clustering within households.

Limitations and Future Work

The authors acknowledge several limitations:

  • Exclusion of Children: The study excluded individuals younger than 14 years, which may lead to an underestimation of overall household transmission and population-level seroprevalence.
  • Exclusion of Institutionalized Populations: Residents of nursing homes and other institutions were not included, potentially affecting the generalizability of the findings.
  • Timing of Data Collection: While the study was conducted after the first wave, the timing of questionnaire completion relative to blood sample collection (up to six weeks) could introduce recall bias for symptoms.
  • Low Power for Risk Factor Analysis: Despite a large sample size, the relatively low seroprevalence limited the statistical power to identify strong risk factors, resulting in wide confidence intervals.

Future work suggested includes:

  • Longitudinal Studies: Continued monitoring through longitudinal cohort studies is essential to understand the long-term correlates of protection and the evolving seroprevalence.
  • Further Investigation of Clustering: More research is needed to confirm the weak suggestions of clustering within buildings and neighborhoods.
  • Understanding Antibody Meaning: Further research is required to clarify the meaning of detected SARS-CoV-2-specific antibodies and their correlation with protection.

Summary updated

Abstract

Given the large number of mild or asymptomatic SARS-CoV-2 cases, only population-based studies can provide reliable estimates of the magnitude of the pandemic. We therefore aimed to assess the sero-prevalence of SARS-CoV-2 in the Munich general population after the first wave of the pandemic. For this purpose, we drew a representative sample of 2994 private households and invited household members 14 years and older to complete questionnaires and to provide blood samples. SARS-CoV-2 seropositivity was defined as Roche N pan-Ig ≥ 0.4218. We adjusted the prevalence for the sampling design, sensitivity, and specificity. We investigated risk factors for SARS-CoV-2 seropositivity and geospatial transmission patterns by generalized linear mixed models and permutation tests. Seropositivity for SARS-CoV-2-specific antibodies was 1.82% (95% confidence interval (CI) 1.28-2.37%) as compared to 0.46% PCR-positive cases officially registered in Munich. Loss of the sense of smell or taste was associated with seropositivity (odds ratio (OR) 47.4; 95% CI 7.2-307.0) and infections clustered within households. By this first population-based study on SARS-CoV-2 prevalence in a large German municipality not affected by a superspreading event, we could show that at least one in four cases in private households was reported and known to the health authorities. These results will help authorities to estimate the true burden of disease in the population and to take evidence-based decisions on public health measures.
BibTeX
@article{pritsch2021prevalence,
  author = {Michael Pritsch and Katja Radon and Abhishek Bakuli and Ronan Le Gleut and Laura Olbrich and Jessica Guggenbüehl Noller and Elmar Saathoff and Noemi Castelletti and Mercè Garí and Peter Pütz and Yannik Schälte and Turid Frahnow and Roman Wölfel and Camilla Rothe and Michel Pletschette and Dafni Metaxa and Felix Forster and Verena Thiel and F. Rieß and Maximilian N. Diefenbach and Günter Fröschl and Jan Bruger and Simon Winter and Jonathan Frese and Kerstin Puchinger and Isabel Brand and Inge Kroidl and Jan Hasenauer and Christiane Fuchs and Andreas Wieser and Michael Höelscher and on behalf of the KoCo19 study group},
  title = {{Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich}},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2021},
  doi = {10.3390/ijerph18073572},
}
Figure